These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1828835)

  • 1. Species differences in percutaneous absorption of nicorandil.
    Sato K; Sugibayashi K; Morimoto Y
    J Pharm Sci; 1991 Feb; 80(2):104-7. PubMed ID: 1828835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the in-vitro human skin permeability of nicorandil from animal data.
    Sato K; Sugibayashi K; Morimoto Y; Omiya H; Enomoto N
    J Pharm Pharmacol; 1989 Jun; 41(6):379-83. PubMed ID: 2570832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for percutaneous absorption.
    Jung EC; Maibach HI
    J Appl Toxicol; 2015 Jan; 35(1):1-10. PubMed ID: 25345378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive effects and biotransformation of nicorandil, a new antianginal agent, administered to rats by different routes: comparison with nitroglycerin and isosorbide dinitrate.
    Sakai K; Akima M; Hinohara Y; Obatake N
    J Pharm Pharmacol; 1984 Mar; 36(3):175-81. PubMed ID: 6144752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of skin thickness on the in vitro permeabilities of drugs through Sprague-Dawley rat or Yucatan micropig skin.
    Takeuchi H; Ishida M; Furuya A; Todo H; Urano H; Sugibayashi K
    Biol Pharm Bull; 2012; 35(2):192-202. PubMed ID: 22293349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of footshock stress on pharmacokinetics of nicorandil in rats.
    Yamori M; Gomita Y; Oishi R
    Life Sci; 1991; 48(21):2065-73. PubMed ID: 1827856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies.
    Davies DJ; Ward RJ; Heylings JR
    Toxicol In Vitro; 2004 Jun; 18(3):351-8. PubMed ID: 15046783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective penetration enhancing effect of carvone on the in vitro transdermal permeation of nicorandil.
    Krishnaiah YS; Nada A
    Pharm Dev Technol; 2012; 17(5):574-82. PubMed ID: 21428701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of rat skin as a substitute for human skin in the in vitro skin permeation study.
    Takeuchi H; Mano Y; Terasaka S; Sakurai T; Furuya A; Urano H; Sugibayashi K
    Exp Anim; 2011; 60(4):373-84. PubMed ID: 21791877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
    Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
    Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the percutaneous absorption of hydrophilic and lipophilic compounds in shed snake skin and human skin.
    Ngawhirunpat T; Panomsuk S; Opanasopit P; Rojanarata T; Hatanaka T
    Pharmazie; 2006 Apr; 61(4):331-5. PubMed ID: 16649549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of skin permeability of drugs: comparison of human and hairless rat skin.
    Morimoto Y; Hatanaka T; Sugibayashi K; Omiya H
    J Pharm Pharmacol; 1992 Aug; 44(8):634-9. PubMed ID: 1359085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and simple determination of nicorandil in rat plasma using a solid-phase extraction column.
    Gomita Y; Furuno K; Eto K; Fukuda T; Araki Y; Yamori M; Oishi R
    J Chromatogr; 1990 Jun; 528(2):509-16. PubMed ID: 2143508
    [No Abstract]   [Full Text] [Related]  

  • 14. Formulation optimization and stability study of transdermal therapeutic system of nicorandil.
    Tipre DN; Vavia PR
    Pharm Dev Technol; 2002; 7(3):325-32. PubMed ID: 12229264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for transdermal drug delivery.
    Panchagnula R; Stemmer K; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):335-41. PubMed ID: 9379782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of nicorandil on ATP-sensitive K+ channel in guinea-pig ventricular myocytes.
    Nakayama K; Fan Z; Marumo F; Sawanobori T; Hiraoka M
    Br J Pharmacol; 1991 Jul; 103(3):1641-8. PubMed ID: 1834294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic method for stability and pharmacokinetic studies of nicorandil.
    Bachert EL; Fung HL
    J Chromatogr; 1993 Sep; 619(2):336-41. PubMed ID: 8263109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability.
    Nicoli S; Padula C; Aversa V; Vietti B; Wertz PW; Millet A; Falson F; Govoni P; Santi P
    Skin Pharmacol Physiol; 2008; 21(4):218-26. PubMed ID: 18509256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an alpha hydroxy acid (glycolic acid) on hairless guinea pig skin permeability.
    Hood HL; Kraeling ME; Robl MG; Bronaugh RL
    Food Chem Toxicol; 1999 Nov; 37(11):1105-11. PubMed ID: 10566882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers.
    Krishnaiah YS; Al-Saidan SM; Chandrasekhar DV; Satyanarayana V
    J Control Release; 2005 Aug; 106(1-2):111-22. PubMed ID: 15993975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.